Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

pegylated granulocyte colony-stimulating factor

Known as: mecapegfilgrastim 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background This study aimed to evaluate the efficacy and safety of mecapegfilgrastim (HHPG-19K) with different doses compared to… Expand
Is this relevant?
2019
2019
Background Neutropenia is a common complication from chemotherapy. Mecapegfilgramtim (code name HHPG-19K), a long-acting… Expand
Is this relevant?
2019
2019
Background: Neutropenia is a common complication from chemotherapy. Mecapegfilgramtim (code name HHPG-19K), a long-acting… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2019
2019
Background: This study aimed to evaluate the efficacy and safety of mecapegfilgrastim (HHPG-19K) with different doses compared to… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2019
Review
2019
  • Yong Wang, Lin Chen, +4 authors Yong Li
  • Scientific Reports
  • 2019
The optimum granulocyte colony-stimulating factor (G-CSF) treatment for cancer patients after being treated with cytotoxic… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2019
2019
Chemotherapy is still one of the main tools for treatment of pediatric and adult blood and solid tumors and is capable of cure… Expand
Is this relevant?
Review
2019
Review
2019
Mecapegfilgrastim (HHPG-19K) is a long-acting pegylated recombinant human granulocyte-colony stimulating factor (rhG-CSF) that is… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2016
2016
BACKGROUND Mecapegfilgrastim (code name HHPG-19K) is a biosimilar to pegylated recombinant human granulocyte-colony stimulating… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?